跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NOREPINEPHRINE BITARTRATE INJECTION USP - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NOREPINEPHRINE BITARTRATE INJECTION USP
Authorized
STANDARD
NOREPINEPHRINE BITARTRATE INJECTION USP
generic medical partners inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e615a7d2c456a6c5
Company
generic medical partners inc
Type
Standard
Approval Details
Approval Id
e615a7d2c456a6c5
Drug Approval Canada Name
NOREPINEPHRINE BITARTRATE INJECTION USP
Product Name
NOREPINEPHRINE BITARTRATE INJECTION USP
Status
Marketed
Status Date
2020-05-04
Original Market Date
2020-05-04
Din
02485680
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Ethical
Ahfs
12:12.12
Atc Original
C01CA03 NOREPINEPHRINE
Atc Name
c 01 ca 03
Aig Number
0131301001
Company Name
generic medical partners inc
Company Address
1500 Don Mills Road, Suite 711, Toronto, Ontario, Canada, M3B 3K4
Active Ingredients
NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)
1 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e615a7d2c456a6c5
Type
Standard
Back to Health Canada Approvals